Information  X 
Enter a valid email address

Medaphor Group PLC (MED)

  Print      Mail a friend       Annual reports

Wednesday 12 December, 2018

Medaphor Group PLC

Results of Open Offer

RNS Number : 1769K
Medaphor Group PLC
12 December 2018

The information contained within this announcement (the "Announcement") is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this Announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.


MedaPhor Group plc

("MedaPhor" or the "Company")

Results of Open Offer

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that further to the announcement of the Placing and Open Offer on 26 November 2018, it has conditionally raised total gross proceeds of £78,778 via the Open Offer.

The Open Offer closed for acceptances at 11.00 a.m. on 11 December 2018. The Company received valid acceptances from Qualifying Shareholders in respect of 926,801 Open Offer Shares, including applications for 63,354 Open Offer Shares under the Excess Application Facility. This represents 3.8 per cent. of the maximum Open Offer Shares available under the Open Offer. Admission of the Open Offer shares is subject to passing the relevant resolutions at the General Meeting.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 26 November 2018.


MedaPhor Group plc 

Stuart Gall, CEO 
Wilson Jennings, CFO

Tel: +44 (0)29 2075 6534 

Cenkos Securities - Nominated Advisor and broker

Tel:  +44 (0)20 7397 8900 

Mark Connelly / Cameron MacRitchie (Corporate Finance)

Michael Johnson / Julian Morse (Sales) 

Walbrook PR 

Tel: +44 (0)20 7933 8780 or [email protected] 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t